UiPath Inc: BMO cuts target price to $15 from $18
PATH•BMO cut its target price for UiPath to $15 from $18.
Related News
MOIA America, Beep begin passenger rides in Orlando
VWAGY•
Acadia falls after Alzheimer's-related drug narrowly misses goal in study
ACAD•
Frontier Group Holdings: UBS cuts target price to $6 from $7
ULCC•
Ligand enters financing deal with AvenCell Therapeutics for up to $47 million
LGND•
Immuneering MAPKeeper-301 Phase 3 pancreatic cancer trial abstract wins ESMO 2026 poster slot
IMRX•